Correlation Between Krebs Biochemicals and Paramount Communications

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and Paramount Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and Paramount Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krebs Biochemicals and and Paramount Communications Limited, you can compare the effects of market volatilities on Krebs Biochemicals and Paramount Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of Paramount Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and Paramount Communications.

Diversification Opportunities for Krebs Biochemicals and Paramount Communications

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Krebs and Paramount is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and Paramount Communications Limit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paramount Communications and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with Paramount Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paramount Communications has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and Paramount Communications go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and Paramount Communications

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to generate 1.63 times more return on investment than Paramount Communications. However, Krebs Biochemicals is 1.63 times more volatile than Paramount Communications Limited. It trades about 0.12 of its potential returns per unit of risk. Paramount Communications Limited is currently generating about 0.0 per unit of risk. If you would invest  6,360  in Krebs Biochemicals and on August 30, 2024 and sell it today you would earn a total of  4,933  from holding Krebs Biochemicals and or generate 77.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Krebs Biochemicals and  vs.  Paramount Communications Limit

 Performance 
       Timeline  
Krebs Biochemicals and 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Paramount Communications 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Paramount Communications Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Krebs Biochemicals and Paramount Communications Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krebs Biochemicals and Paramount Communications

The main advantage of trading using opposite Krebs Biochemicals and Paramount Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, Paramount Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paramount Communications will offset losses from the drop in Paramount Communications' long position.
The idea behind Krebs Biochemicals and and Paramount Communications Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency